Your Article Summary
See Latest ArticlesVitreomacular Adhesion in Active and End-Stage Age-related Macular Degeneration
American Journal of Ophthalmology, 06/26/09
Robison CD et al. - PVD may protect against exudative AMD, whereas VMA may promote exudative AMD. This phenomenon is not evident in end-stage disease because of an increased incidence of PVD and a decreased incidence of VMA in eyes with disciform scars. Genetic and environmental factors do not seem to influence these observations.
Related Articles
Intravitreal bevacizumab for treatment-naive patients with subfoveal occult choroidal neovascularization secondary to age-related macular degeneration
Retina, 11/11/09
Relevance Score: 68%
Statin Use and the Incidence of Advanced Age-Related Macular Degeneration in the Complications of Age-Related Macular Degeneration Prevention Trial
Ophthalmology, 10/28/09
Relevance Score: 68%
siRNA therapeutics for age-related macular degeneration: promises and pitfalls
Expert Review of Ophthalmology, 10/22/09
Relevance Score: 68%
Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
American Journal of Ophthalmology, 10/07/09
Relevance Score: 67%
Efficacy of 12-month treatment of neovascular age-related macular degeneration with intravitreal bevacizumab based on individually determined injection strategies after three consecutive monthly injections
Acta Ophthalmologica, 11/11/09
Relevance Score: 66%
Today in Retina...keeping you current
Receive free subspecialty "5-minute updates" via email
Retinal astrocytes respond to IL-17 differently than retinal pigment epithelial cells
Journal of Leukocyte Biology, 12/04/09
Visual Impairment and quality of life in the Older European Population, the EUREYE study
Acta Ophthalmologica, 12/03/09
Downregulation of Serum IGF-1 for Treatment of Early Worsening of Diabetic Retinopathy: A Long-Term Follow-Up of Two Cases
Ophthalmologica, 12/03/09